Alkem Laboratories Limited has announced its 52nd Annual General Meeting (AGM), scheduled for Thursday, 27 August, 2026, at 11:00 AM. The meeting will be conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM). Shareholders will receive the Audited Standalone and Consolidated Financial Statements for the financial year ended 31 March, 2026, along with the Directors’ and Auditors’ reports. The agenda also includes confirming the payment of Interim Dividend and declaring the Final Dividend.
Alkem Laboratories Announces 52nd Annual General Meeting
Alkem Laboratories Limited has officially announced that its 52nd Annual General Meeting (AGM) will take place on Thursday, 27 August, 2026, at 11:00 am. The meeting will be conducted virtually through Video Conferencing (VC) and Other Audio Visual Means (OAVM), with the registered office of the Company deemed the venue.
Key Agenda Items
The primary business of the AGM will include the consideration and adoption of the Audited Standalone Financial Statements for the financial year ended 31 March, 2026, along with the Reports of the Board of Directors and Auditors. Furthermore, the Audited Consolidated Financial Statements for the same period, along with the Auditors’ Report, will be presented. Shareholders will also be asked to confirm the payment of the Interim Dividend and declare the Final Dividend on Equity Shares for the financial year ended 31 March, 2026.
Director Appointments
The AGM will also address the appointment of directors. Mr. Sandeep Singh (DIN: 01277984), who is retiring by rotation and being eligible, will be considered for re-appointment. Similarly, Mr. Sarvesh Singh (DIN: 01278229), also retiring by rotation and eligible, will be considered for re-appointment. Additionally, the re-appointment of Mrs. Madhurima Singh (DIN: 09137323) as an Executive Director is on the agenda, with proposed terms and remuneration detailed in the explanatory statement.
Source: BSE
